Fareston is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Kyowa Kirin, Inc,. The primary component is Toremifene Citrate.
| Product ID | 42747-327_6ff72243-bef4-4ce1-a51d-7912e637860c |
| NDC | 42747-327 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Fareston |
| Generic Name | Toremifene Citrate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1997-06-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020497 |
| Labeler Name | KYOWA KIRIN, INC, |
| Substance Name | TOREMIFENE CITRATE |
| Active Ingredient Strength | 60 mg/1 |
| Pharm Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1997-06-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020497 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1997-06-30 |
| Marketing Category | NDA |
| Application Number | NDA020497 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1997-06-30 |
| Marketing End Date | 2016-10-27 |
| Marketing Category | NDA |
| Application Number | NDA020497 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1997-06-30 |
| Ingredient | Strength |
|---|---|
| TOREMIFENE CITRATE | 60 mg/1 |
| SPL SET ID: | 2cab8dd1-3a10-48e6-86ce-0e5275ed49e5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 42747-327 | Fareston | toremifene citrate |
| 64980-404 | Toremifene Citrate | Toremifene Citrate |
| 69539-152 | toremifene citrate | toremifene citrate |
| 72205-050 | toremifene citrate | toremifene citrate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FARESTON 73575128 1460565 Live/Registered |
FARMOS-YHTYMA OY (FARMOS GROUP LTD.) 1985-12-24 |